Stay updated on Pembrolizumab in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Gastric Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page’s footer revision label has been updated from v3.5.2 to v3.5.3, indicating a site software/version release rather than a change to the clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-24T06:15:19.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:38:44.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T06:01:55.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page revision was updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T03:24:06.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    Added a link to the Genetic and Rare Diseases Information Center as a resource and included the 'Gastric cancer' term; removed the funding-status notice and an older revision note.
    Difference
    0.5%
    Check dated 2026-02-11T16:22:44.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding and NIH operations. Updated page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T10:45:18.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Gastric Cancer Clinical Trial page.